C000010380 Fees and Costs — Biotechnology Fund, Variable Annuity
Data updated: 2026-08-21
The net expense ratio is 1.79%: a 0.85% management fee plus 0.99% other expenses, less a 0.05% fee waiver. There are no sales loads or redemption fees. In fiscal 2025 the fund paid $24K in broker commissions, 0.2340% of average net assets, and portfolio turnover was 553%.
C000010380 Fees and Expenses
Annual operating expenses and sales charges of C000010380. Prospectus, as of December 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.85% |
| 12b-1 fee | — |
| Other expenses | 0.99% |
| Gross expense ratio | 1.84% |
| Fee waiver | −0.05% |
| Net expense ratio | 1.79% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
C000010380 Costs Over Time
On $10,000 invested in C000010380, assuming 5% a year before costs, total costs come to $1,240 over 5 years, cutting the return by 2.13% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 1.79%) | $188 | $580 | $995 |
| Trading costs (broker commissions) | $25 | $76 | $130 |
| Lost growth on money paid in costs | $0 | $33 | $115 |
| Total costs | $213 | $689 | $1,240 |
| Value after costs | $10,287 | $10,887 | $11,522 |
| Impact on return, per year | 2.13% | 2.13% | 2.13% |
C000010380 Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending December 31, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.2340%
- Total broker commissions: $24K
- Bought from dealers (principal trades, not a cost): $20.5M
- Portfolio turnover (prospectus): 553%
- Securities on loan, average value: $143K
- Net income from securities lending: $2K (0.024% of average net assets)
C000010380 Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Roth Capital Partners | $9K | 38.08% |
| BOFA SECURITIES, INC. | $6K | 23.67% |
| BARCLAYS CAPITAL INC. | $5K | 22.64% |
| Instinet, LLC | $3K | 14.72% |
| BTIG, LLC | $199 | 0.84% |
| CANTOR FITZGERALD & CO. | $12 | 0.05% |
C000010380 Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| J.P. MORGAN SECURITIES LLC | $10.3M | 50.31% |
| BOFA SECURITIES, INC. | $4.9M | 23.86% |
| BARCLAYS CAPITAL INC. | $4.7M | 23.00% |
| TENDER OFFER | $578K | 2.83% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.